col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


382 Results       Page 1

 [1] 
Oxford University Press: The Journal of Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―12 Nirmatrelvir/ritonavir Use and Hospitalizations or Death in Previously Uninfected Non-hospitalized High-risk Population with COVID-19: A matched cohort study Adeel A Butt, Peng Yan, Obaid S Shaikh, Victor B Talisa, Saad B Omer, Florian B Mayr
2 [GO] 2023―Sep―08 IL-13 induced inflammation increases DPP4 abundance but does not enhance MERS-CoV replication in airway epithelia Kun Li, Jennifer A Bartlett, Christine L Wohlford-Lenane, Biyun Xue, Andrew L Thurman, Thomas M Gallagher, et al. (+2)
3 [GO] 2023―Sep―06 Primary exposure to SARS-CoV-2 via infection or vaccination determines mucosal antibody-dependent ACE2 binding inhibition Janeri Fröberg, Vera J C H Koomen, Christa E van der Gaast-de Jongh, Ria Philipsen, Corine H GeurtsvanKessel, Rory D de Vries, et al. (+21)
4 [GO] 2023―Aug―23 Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune response in diabetic and control pediatric patients Alan Sariol, Molly A Vickers, Shannon M Christensen, Daniela Weiskopf, Alessandro Sette, Andrew W Norris, et al. (+3)
5 [GO] 2023―Aug―22 Who Gets Sick from COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods, 9/2020-11/2021 Stanley C Wei, Dane Freeman, Austin Himschoot, Kristie E N Clarke, Miriam E Van Dyke, Jennifer Adjemian, et al. (+14)
6 [GO] 2023―Aug―18 SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds Ninaad Lasrado, Dan H Barouch
7 [GO] 2023―Aug―12 SARS-CoV-2 reinfection cases in a household-based prospective cohort in Rio de Janeiro Stephanie L S Penetra, Heloisa F P Santos, Paola Cristina Resende, Leonardo Soares Bastos, Michele F B da Silva, Anielle Pina-Costa, et al. (+16)
8 [GO] 2023―Aug―11 An observational prospective cohort study of vaccine effectiveness against SARS-CoV-2 infection of an aerosolized, inhaled adenovirus-type-5-vectored COVID-19 vaccine given as a second booster dose in Guangzhou city, China Fu-Zhen Wang, Chun-Huan Zhang, Lin Tang, Lance E Rodewald, Wen Wang, Si-Yu Liu, et al. (+9)
9 [GO] 2023―Aug―11 Differential Sars-Cov-2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough Subjects Luisa F Duarte, Yaneisi Vázquez, Benjamín Diethelm-Varela, Valentina Pavez, Roslye Berríos-Rojas, Constanza Mendez, et al. (+5)
10 [GO] 2023―Aug―10 Interpreting the results of trials of BCG vaccination for protection against COVID-19 Christie CA Noble, Nicole L Messina, Laure F Pittet, Nigel Curtis
11 [GO] 2023―Aug―10 An ACE2-based bimodular fusion protein enables reorientation of endogenous anti-Epstein-Barr virus antibodies towards SARS-CoV-2 Spike Arnaud Chêne, Alexandra Desrames, Alice Tomlinson, Claude Ruffié, Frédéric Tangy, Benoît Gamain
12 [GO] 2023―Aug―10 Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir as treatments for COVID-19 in high-risk patients D Paraskevis, M Gkova, K Mellou, G Gerolymatos, Ν Psalida, K Gkolfinopoulou, et al. (+13)
13 [GO] 2023―Aug―07 Herpes zoster reactivation after mRNA and adenovirus-vectored coronavirus disease 2019 vaccination: Analysis of National Health Insurance Database Jin Gu Yoon, Young-Eun Kim, Min Joo Choi, Won Suk Choi, Yu Bin Seo, Jaehun Jung, et al. (+8)
14 [GO] 2023―Aug―03 COVID-19 outcomes among people with HIV and COVID-19 in New York City Sarah L Braunstein, Amanda Wahnich, Rachael Lazar
15 [GO] 2023―Aug―03 Neuronal and Glial Metabolite Abnormalities in Participants with Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton MR Spectroscopy Study Thomas Ernst, Meghann C Ryan, Hua-Jun Liang, Justin P Wang, Eric Cunningham, Muhammad G Saleh, et al. (+2)
16 [GO] 2023―Aug―02 Stroke Following COVID-19 Vaccination: Evidence Based on Different Designs of Real-World Studies Junyu Liu, Fang Cao, Chun Luo, Yuxin Guo, Junxia Yan
17 [GO] 2023―Jul―21 Year-round RSV Transmission in the Netherlands Following the COVID-19 Pandemic - A Prospective Nationwide Observational and Modeling Study Yvette N Löwensteyn, Zhe Zheng, Neele Rave, Michiel A G E Bannier, Marie-Noëlle Billard, Jean-Sebastien Casalegno, et al. (+67)
18 [GO] 2023―Jul―19 Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) Charlotte Hedskog, Lauren Rodriguez, Pavitra Roychoudhury, Meei-Li Huang, Keith R Jerome, Linhui Hao, et al. (+8)
19 [GO] 2023―Jul―19 Clinical antiviral efficacy of remdesivir in COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV) Podjanee Jittamala, William H K Schilling, James A Watson, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, et al. (+36)
20 [GO] 2023―Jul―13 Superior boosting of neutralizing titers against Omicron SARS-CoV-2 variants by heterologous SCB-2019 vaccine vs a homologous booster in CoronaVac-primed adults Camilo C Roa, Mari Rose A de Los Reyes, Eric Plennevaux, Igor Smolenov, Branda Hu, Faith Gao, et al. (+4)
21 [GO] 2023―Jul―07 T-cell immunity against SARS-CoV-2 measured by an interferon-γ release assay is strongly associated with patient outcomes in vaccinated persons hospitalized with Delta or Omicron variants Marta Fernández-González, Vanesa Agulló, José Alberto García, Sergio Padilla, Javier García-Abellán, Alba de la Rica, et al. (+3)
22 [GO] 2023―Jun―24 Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong Jessica Y Wong, Justin K Cheung, Yun Lin, Helen S Bond, Eric H Y Lau, Dennis K M Ip, et al. (+2)
23 [GO] 2023―Jun―22 Lessons (machine) learned from COVID-19 Timothy Sullivan
24 [GO] 2023―Jun―21 Foreword: Preventing COVID-19 Among the Immunocompromised Population Michelle Willicombe
25 [GO] 2023―Jun―15 Utility of Plasma Microbial Cell-Free DNA Whole-Genome Sequencing for Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancy or COVID-19 Ki Hyun Lee, Dongju Won, Jinnam Kim, Jung Ah Lee, Chang Hyup Kim, Jung Ho Kim, et al. (+11)
26 [GO] 2023―Jun―09 Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated with AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants Kevin M Tuffy, Bahar Ahani, Anastasia A Aksyuk, Miles Avila, Tyler Brady, Gustavo H Kijak, et al. (+9)
27 [GO] 2023―Jun―09 De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Maria Rebelo, Cong Tang, Ana R Coelho, Carlos Labão-Almeida, Matthias M Schneider, Laurie Tatalick, et al. (+12)
28 [GO] 2023―Jun―09 Bivalent Coronavirus Disease 2019 Vaccine Antibody Responses to Omicron Variants Suggest That Responses to Divergent Variants Would Be Improved With Matched Vaccine Antigens Wei Wang, Emilie Goguet, Stephanie Paz, Russell Vassell, Simon Pollett, Edward Mitre, Carol D Weiss
29 [GO] 2023―Jun―08 Use of Next Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-CoV-2 Pandemic on HIV-1 Diagnosis and Transmission Shuntai Zhou, Nathan Long, Matt Moeser, Collin S Hill, Erika Samoff, Victoria Mobley, et al. (+11)
30 [GO] 2023―Jun―02 National Trends in Anticoagulation Therapy for COVID-19 Hospitalized Adults in the United States: Analyses of the National COVID Cohort Collaborative Eileen Lee, Benjamin Bates, Nathaniel Kuhrt, Kathleen M Andersen, Aayush Visaria, Rachel Patel, et al. (+6)
31 [GO] 2023―Jun―01 Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in an HIV cohort in Lesotho: correlates of antibody response and seropositivity Jennifer A Brown, Anthony Hauser, Irene A Abela, Chloé Pasin, Selina Epp, Tsepang Mohloanyane, et al. (+5)
32 [GO] 2023―Jun―01 Molnupiravir Use and 30-Day Hospitalizations or Death in Previously Uninfected Non-hospitalized High-risk Population with COVID-19 Adeel A Butt, Peng Yan, Obaid S Shaikh, Saad B Omer, Florian B Mayr, Victor B Talisa
33 [GO] 2023―May―25 The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future Andrea Antinori, Mary Bausch-Jurken
34 [GO] 2023―May―24 Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases Axel Finckh, Adrian Ciurea, Catherine E Raptis, Andrea Rubbert-Roth
35 [GO] 2023―May―24 COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future Nadine Rouphael, Mary Bausch-Jurken
36 [GO] 2023―May―24 Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants Vijay Subramanian
37 [GO] 2023―May―24 A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations Paolo Bonanni, Francesca Ceddia, Rachel Dawson
38 [GO] 2023―May―24 COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future Victoria G Hall, Benjamin W Teh
39 [GO] 2023―May―24 SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies Robert Paris
40 [GO] 2023―May―21 Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 SARS-CoV-2 Primary Vaccination Louis Fries, Neil Formica, Raburn M Mallory, Haixia Zhou, Joyce S Plested, Raj Kalkeri, et al. (+26)
41 [GO] 2023―May―19 Environmental impact assessment for the use of an orally aerosolised adenovirus type-5 vector-based COVID-19 vaccine in randomised clinical trials Xin Xia, Zhong-Ming Tan, Peng Wan, Hao Zheng, Rong Tang, Xiao-Qin Chen, et al. (+8)
42 [GO] 2023―May―17 SARS-CoV-2 Delta variant genomic variation associated with breakthrough infection in Northern California: A retrospective cohort study Jacek Skarbinski, Joshua R Nugent, Mariah S Wood, Liyan Liu, Teal Bullick, Jeffrey M Schapiro, et al. (+8)
43 [GO] 2023―May―04 Immunogenicity and reactogenicity of mRNA COVID-19 vaccine booster administered by intradermal or intramuscular route in Thai Older adults Prasert Assantachai, Suvimol Niyomnaitham, Wichai Chatthanawaree, Somboon Intalapaporn, Weerasak Muangpaisan, Harisd Phannarus, et al. (+7)
44 [GO] 2023―Apr―27 Accelerated T cell immunosenescence in CMV-seropositive individuals after SARS-CoV-2 infection Pablo Álvarez-Heredia, Irene Reina-Alfonso, Jose Joaquín Domínguez-del Castillo, Carmen Gutiérrez-González, Fakhri Hassouneh, Alexander Batista-Duharte, et al. (+4)
45 [GO] 2023―Apr―27 Binding and avidity signatures of polyclonal sera from individuals with different exposure histories to SARS-CoV-2 infection, vaccination, and Omicron breakthrough infections Gagandeep Singh, Anass Abbad, Johnstone Tcheou, Demodara Rao Mendu, Adolfo Firpo-Betancourt, Charles Gleason, et al. (+5)
46 [GO] 2023―Apr―24 Residential clustering of COVID-19 cases and efficiency of building-wide compulsory testing notices as a transmission control measure in Hong Kong Benjamin R Young, Bingyi Yang, Peng Wu, Dillon C Adam, Jessica Y Wong, Faith Ho, et al. (+4)
47 [GO] 2023―Apr―24 Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022 Christina E Hoeve, Brechje de Gier, Anne J Huiberts, Hester E de Melker, Susan J M Hahné, Susan van den Hof, Mirjam J Knol
48 [GO] 2023―Apr―17 A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New SARS-CoV-2 Variants of Concern Nicholas P Wayham, Ariel R Niedecken, Jan Fredrik Simons, Yao Y Chiang, Angélica V Medina-Cucurella, Rena A Mizrahi, et al. (+14)
49 [GO] 2023―Apr―10 Pandemic Preparedness and Response: Lessons from COVID-19 Anthony S Fauci, Gregory K Folkers
50 [GO] 2023―Apr―05 Bivalent COVID-19 Vaccines: Can the Original Antigenic Sin Be Forgiven? Joel N Blankson
51 [GO] 2023―Apr―03 Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study Lin Tang, Fu-Zhen Wang, Lance E Rodewald, Xuan-Yi Wang, Si-Yu Liu, Qian-Qian Liu, et al. (+24)
52 [GO] 2023―Mar―27 Population-Based Severe Acute Respiratory Syndrome Coronavirus 2 Whole-Genome Sequencing and Contact Tracing During the Coronavirus Disease 2019 Pandemic in Switzerland Nanina Anderegg, Tiana Schwab, Loïc Borcard, Catrina Mugglin, Bettina Keune-Dübi, Alban Ramette, Lukas Fenner
53 [GO] 2023―Mar―25 The relationship between SARS-CoV-2 neutralising antibody titres and avidity in plasma collected from convalescent non-vaccinated and vaccinated blood donors Visa Nurmi, Chanice Knight, Lise Estcourt, Jussi Hepojoki, Abigail A Lamikanra, Hoi Pat Tsang, et al. (+6)
54 [GO] 2023―Mar―08 Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants Derek E Dimcheff, Christopher N Blair, Yuwei Zhu, James D Chappell, Manjusha Gaglani, Tresa McNeal, et al. (+35)
55 [GO] 2023―Mar―04 The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis and Panoptosis Luca Schifanella, Jodi Anderson, Garritt Wieking, Peter J Southern, Spinello Antinori, Massimo Galli, et al. (+5)
56 [GO] 2023―Mar―02 Antibody Responses to the SARS-CoV-2 Ancestral Strain and Omicron Variants in Moderna mRNA-1273 Vaccinated Active-Duty U.S. Navy Sailors and Marines Peifang Sun, Corey A Balinsky, Le Jiang, Vihasi Jani, Tran Khanh Long, Ying Cheng, et al. (+16)
57 [GO] 2023―Feb―23 Surveillance for multisystem inflammatory syndrome in U.S. children aged 5-11 years who received Pfizer-BioNTech COVID-19 vaccine, November 2021-March 2022 Margaret M Cortese, Allan W Taylor, Lara J Akinbami, Andrea Thames-Allen, Anna R Yousaf, Angela P Campbell, et al. (+16)
58 [GO] 2023―Feb―18 Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections Julio A Huapaya, Jeanette Higgins, Shreya Kanth, Cumhur Demirkale, Salina Gairhe, Etsubdink A Aboye, et al. (+38)
59 [GO] 2023―Feb―18 Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance Catherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, Shaun Grannis, Paul Drawz, Emily Hartmann, et al. (+24)
60 [GO] 2023―Feb―16 Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Among University Students in Western Pennsylvania Vatsala Rangachar Srinivasa, Marissa P Griffith, Kady D Waggle, Monika Johnson, Lei Zhu, John V Williams, et al. (+4)
61 [GO] 2023―Feb―13 The Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection on Neutralizing Antibodies: A Nation-wide Cross-sectional Analysis Thomas Althaus, Jordi Landier, Feng Zhu, Hervé Raps, Olivier Dejoux, Alizée Costantini, et al. (+6)
62 [GO] 2023―Feb―10 CASP4/11 contributes to NLRP3 activation and COVID-19 exacerbation Tamara S Rodrigues, Camila C S Caetano, Keyla S G de Sá, Leticia Almeida, Amanda Becerra, Augusto V Gonçalves, et al. (+19)
63 [GO] 2023―Feb―02 Incidence and predictors of breakthrough and severe breakthrough infections of SARS-CoV-2 after primary series vaccination in adults: A population-based survey of 22,575 participants Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, Luis León-Novelo, Yashar Talebi, Melissa A Valerio-Shewmaker, et al. (+13)
64 [GO] 2023―Feb―02 CCL19 (rs3136658) and CCL21 (rs2812377) variants are associated with susceptibility and related mortality of SARS-CoV-2 infection: a population-based correlation analysis Nisha Nayak, Abhijit Pati, Y Pavani, Sourav Sahu, Sudhanshu Ranjan, Aditya K Panda
65 [GO] 2023―Feb―02 Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020 Namrata Prasad, Julia Rhodes, Li Deng, Natalie Mccarthy, Heidi L Moline, James Baggs, et al. (+20)
66 [GO] 2023―Jan―24 The continuing puzzle of defining duration of SARS-CoV-2 infectivity Joshua T Schiffer
67 [GO] 2023―Jan―23 Safety, Tolerability and Pharmacokinetics of Half-Life Extended SARS-CoV-2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab/Cilgavimab) in Healthy Adults Pablo Forte-Soto, Muna Albayaty, Dennis Brooks, Rosalinda H Arends, John Tillinghast, Anastasia A Aksyuk, et al. (+9)
68 [GO] 2023―Jan―23 Association of culturable-virus detection and household transmission of SARS-CoV-2 - California and Tennessee, 2020-2022 Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, Gaston Bonenfant, Scott Lu, Khamal Anglin, et al. (+28)
69 [GO] 2023―Jan―20 Phase 2 safety and antiviral activity of SAB-185, a novel polyclonal antibody therapy for non-hospitalized adults with COVID-19 Babafemi O Taiwo, Kara W Chew, Carlee Moser, David Alain Wohl, Eric S Daar, Jonathan Z Li, et al. (+13)
70 [GO] 2023―Jan―14 BNT162b2 effectiveness against Delta and Omicron variants of SARS-CoV-2 in adolescents aged 12-17 years, by dosing interval and duration Iulia G Ionescu, Danuta M Skowronski, Chantal Sauvageau, Erica Chuang, Manale Ouakki, Shinhye Kim, Gaston De Serres
71 [GO] 2023―Jan―10 Pfizer-BioNTech COVID-19 vaccine effectiveness against SARS-CoV-2 infection among long-term care facility staff with and without prior infection in New York City, January-June 2021 Kathryn Peebles, Robert J Arciuolo, Anthony S Romano, Jessica Sell, Sharon K Greene, Sungwoo Lim, et al. (+11)
72 [GO] 2023―Jan―05 The Association Between COVID-19 and Lung Function: A Mendelian Randomization Analysis Shu Ran, Jia Yao, Baolin Liu
73 [GO] 2022―Dec―30 Manufacture and Characterization of GMP-Compliant SARS-COV-2 Cytotoxic T Lymphocytes Yaya Chu, Jordan Milner, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Janet Ayello, et al. (+15)
74 [GO] 2022―Dec―23 Influenza A and respiratory syncytial virus trigger a cellular response that blocks severe acute respiratory syndrome virus 2 infection in the respiratory tract Kieran Dee, Verena Schultz, Joanne Haney, Laura A Bissett, Callum Magill, Pablo R Murcia
75 [GO] 2022―Dec―22 Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity Kayoko Shioda, Yangping Chen, Matthew H Collins, Benjamin A Lopman
76 [GO] 2022―Dec―21 Antibody avidity maturation, following recovery from infection or the booster vaccination, grants breadth in SARS-CoV-2 neutralizing capacity Yu Nakagama, Katherine Candray, Natsuko Kaku, Yuko Komase, Maria-Virginia Rodriguez-Funes, Rhina Dominguez, et al. (+21)
77 [GO] 2022―Dec―08 Correction to: “Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2”
78 [GO] 2022―Dec―05 Characterizing SARS-CoV-2 transcription of subgenomic and genomic RNAs during early human infection using multiplexed droplet digital PCR Hyon S Hwang, Che-Min Lo, Michael Murphy, Tanner Grudda, Nicholas Gallagher, Chun Huai Luo, et al. (+12)
79 [GO] 2022―Dec―05 Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands Tessa van der Maaden, Elizabeth N Mutubuki, Siméon de Bruijn, Ka Yin Leung, Hans Knoop, Jaap Slootweg, et al. (+5)
80 [GO] 2022―Dec―02 Oxidative DNA damage by N4-hydroxycytidine, a metabolite of the SARS-CoV-2 antiviral molnupiravir Hatasu Kobayashi, Yurie Mori, Sharif Ahmed, Yuichiro Hirao, Shinya Kato, Shosuke Kawanishi, et al. (+2)
81 [GO] 2022―Dec―01 Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, Andrew P Costa, Jeffrey C Kwong
82 [GO] 2022―Nov―29 Correction to: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019
83 [GO] 2022―Nov―21 Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared Kalongo Hamusonde, Dunja Nicca, Huldrych F Günthard, Marcel Stöckle, Katharine EA Darling, Alexandra Calmy, et al. (+61)
84 [GO] 2022―Nov―21 Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022 Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, Brian E Dixon, Mark W Tenforde, Mark G Thompson, et al. (+32)
85 [GO] 2022―Nov―21 Use of whole genome sequencing to estimate the contribution of immune evasion and waning immunity on decreasing COVID-19 vaccine effectiveness Margaret L Lind, Richard Copin, Shane McCarthy, Andreas Coppi, Fred Warner, David Ferguson, et al. (+11)
86 [GO] 2022―Nov―18 Factors associated with vaccine-induced T cell immune responses against SARS-CoV-2 in kidney transplant recipients Inga Tometten, Sinje Landmann, Marta Kantauskaite, Joshua Lamberti, Jonas Hillebrandt, Lisa Müller, et al. (+13)
87 [GO] 2022―Nov―17 Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination Marlou J Jongkees, Daryl Geers, Kathryn S Hensley, Wesley Huisman, Corine H GeurtsvanKessel, Susanne Bogers, et al. (+24)
88 [GO] 2022―Nov―17 Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor Marianne R Perera, Edward JD Greenwood, Thomas WM Crozier, Elizabeth G Elder, Janika Schmitt, Colin M Crump, et al. (+3)
89 [GO] 2022―Nov―17 SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza Arnold S Monto, Adam S Lauring, Emily T Martin
90 [GO] 2022―Nov―07 Household transmission dynamics of seasonal human coronaviruses Talia M Quandelacy, Matt D T Hitchings, Justin Lessler, Jonathan M Read, Charles Vukotich, Andrew S Azman, et al. (+6)
91 [GO] 2022―Oct―31 Perturbations in Respiratory Syncytial Virus (RSV) Activity During the SARS-CoV-2 Pandemic Ann R Falsey, Andrew Cameron, Angela R Branche, Edward E Walsh
92 [GO] 2022―Oct―31 Serum neutralization against SARS-CoV-2 variants is heterogenic and depends on vaccination regimen Michael Jäger, Stefanie Dichtl, Rosa Bellmann-Weiler, Markus Reindl, Cornelia Lass-Flörl, Doris Wilflingseder, Wilfried Posch
93 [GO] 2022―Oct―31 SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome Raquel A Binder, Gavin F Fujimori, Catherine S Forconi, George W Reed, Leandro S Silva, Priya Saikumar Lakshmi, et al. (+24)
94 [GO] 2022―Oct―23 Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care-September 2021-February 2022 Kristie E N Clarke, Yun Kim, Jefferson Jones, Adam Lee, Yangyang Deng, Elise Nycz, et al. (+4)
95 [GO] 2022―Oct―20 Longitudinal SARS-CoV-2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid IgG Mark Anderson, Michael Stec, Amy Gosha, Taha Mohammad, Michael Boler, Rebeca Tojo Suarez, et al. (+4)
96 [GO] 2022―Oct―18 Effectiveness of mRNA booster vaccination against mild, moderate, and severe COVID-19 caused by the Omicron variant in a large, population-based, Norwegian cohort Ida Laake, Siri N Skodvin, Kristine Blix, Ida Henriette Caspersen, Håkon K Gjessing, Lene K Juvet, et al. (+6)
97 [GO] 2022―Oct―18 Antibody and T cell subsets analysis unveils an immune profile heterogeneity mediating long-term responses in individuals vaccinated against SARS-CoV-2 Maria Agallou, Olga S Koutsoni, Maria Michail, Paraskevi Zisimopoulou, Ourania Tsitsilonis, Evdokia Karagouni
98 [GO] 2022―Oct―07 Prospective surveillance of respiratory infections in British Antarctic Survey bases during the COVID-19 pandemic Katharine H Ganly, James C Bowyer, Paul W Bird, Nicholas J Willford, Jessica Shaw, Mina Odedra, et al. (+9)
99 [GO] 2022―Oct―06 Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua-Enrich, Núria Pedreño-Lopez, Jordana Muñoz-Basagoiti, Dàlia Raïch-Regué, et al. (+24)
100 [GO] 2022―Oct―06 Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants Frank P Esper, Thamali M Adhikari, Zheng Jin Tu, Yu Wei Cheng, Kim El-Haddad, Daniel H Farkas, et al. (+7)
101 [GO] 2022―Oct―05 The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults Michael Asamoah-Boaheng, David M Goldfarb, Mohammad Ehsanul Karim, Sheila F O’Brien, Nechelle Wall, Steven J Drews, et al. (+3)
102 [GO] 2022―Sep―26 The number of COVID-19 vaccine doses and severe clinical outcomes in older patients infected with a SARS-CoV-2 Omicron variant Koichi Furukawa, Yukiya Kurahashi, Hanako Ishimaru, Mitsuhiro Nishimura, Jun Arii, Shigeru Sano, et al. (+5)
103 [GO] 2022―Sep―21 Restoration of neutralization activity against Omicrons BA.2 and BA.5 in older adults and individuals with risk factors following the 4th-dose of SARS-CoV-2 BNT162b2 vaccine Masayuki Amano, Sachiko Otsu, Yasuko Ichikawa, Nobuyo Higashi-Kuwata, Shuzo Matsushita, Shinya Shimada, Hiroaki Mitsuya
104 [GO] 2022―Sep―20 Characterization of SARS-CoV-2 Omicron variant shedding and predictors of viral culture positivity on vaccinated healthcare workers with mild COVID-19 Alessandra Luna-Muschi, Saidy Vásconez Noguera, Igor C Borges, Anderson V De Paula, Marina Farrel Côrtes, Carolina Larocca, et al. (+15)
105 [GO] 2022―Sep―20 Comparison of the risk of hospitalisation and severe disease among co-circulating SARS-CoV-2 variants Camino Trobajo-Sanmartín, Ana Miqueleiz, Marcela Guevara, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, et al. (+4)
106 [GO] 2022―Sep―14 Regimen of COVID-19 vaccination influences extent and kinetics of antibody avidity Annika Rössler, Janine Kimpel, Verena Fleischer, Silke Huber, Dorothee von Laer, Wegene Borena, Reinhard Würzner
107 [GO] 2022―Sep―10 Correction to: Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
108 [GO] 2022―Sep―09 Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads Following SARS-CoV-2 Infection in Pregnancy Mary C Cambou, Christine M Liu, Thalia Mok, Viviana Fajardo-Martinez, Sophia G Paiola, Francisco J Ibarrondo, et al. (+15)
109 [GO] 2022―Sep―03 A Pilot Trial of Thymalfasin (Tα1) to Treat Hospitalized Patients with Hypoxemia and Lymphocytopenia due to COVID-19 Infection Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, et al. (+2)
110 [GO] 2022―Sep―02 PERSPECTIVE: A Proposal To Name Four Coronaviruses of Limited Virulence “Common Cold Coronaviruses” Kenneth McIntosh, Stanley Perlman, Arnold Monto, Janet A Englund
111 [GO] 2022―Sep―02 Omicron SARS-CoV-2 Neutralization by Immunoglobulin Preparations Manufactured from Plasma Collected in the US and Europe Maria R Farcet, Michael Karbiener, Simone Knotzer, Julia Schwaiger, Thomas R Kreil
112 [GO] 2022―Aug―30 Effectiveness of CoronaVac and BNT162b2 vaccine against SARS-CoV-2 Omicron BA.2 infections in Hong Kong Bingyi Yang, Irene O L Wong, Jingyi Xiao, Tim K Tsang, Qiuyan Liao, Benjamin J Cowling
113 [GO] 2022―Aug―29 Interactions between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human nasal Epithelium Pizzorno Andrés, Padey Blandine, Dulière Victoria, Mouton William, Oliva Justine, Emilie Laurent, et al. (+7)
114 [GO] 2022―Aug―25 Delineating the spread and prevalence of SARS-CoV-2 Omicron sub-lineages (BA.1- BA.5) and Deltacron using wastewater in the Western Cape, South Africa Rabia Johnson, Noluxabiso Mangwana, Jyoti R Sharma, Christo J F Muller, Kholofelo Malemela, Funanani Mashau, et al. (+16)
115 [GO] 2022―Aug―22 Understanding early pandemic SARS-CoV-2 transmission in a medical center by incorporating public sequencing databases to mitigate bias Jacquelyn Turcinovic, Beau Schaeffer, Bradford P Taylor, Tara C Bouton, Aubrey R Odom-Mabey, Sarah E Weber, et al. (+5)
116 [GO] 2022―Aug―18 Enhancement of humoral and cellular immunity against SARS-CoV-2 by a third dose of BNT162b2 vaccine in Japanese healthcare workers Kei Miyakawa, Hideaki Kato, Norihisa Ohtake, Sundararaj Stanleyraj Jeremiah, Akihide Ryo
117 [GO] 2022―Aug―17 HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization Shi-Hsia Hwa, Jumari Snyman, Mallory Bernstein, Yashica Ganga, Sandile Cele, Daniel Muema, et al. (+9)
118 [GO] 2022―Aug―15 Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System Naimisha Movva, Mina Suh, Heidi Reichert, Bradley Hintze, Mark P Sendak, Zachary Wolf, et al. (+8)
119 [GO] 2022―Aug―06 Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery Nathella Pavan Kumar, Aishwarya Venkataraman, Arul Nancy, Kadar Moideen, Poovazhagi Varadarjan, Elilarasi Selladurai, et al. (+8)
120 [GO] 2022―Aug―03 COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors Eduard Grebe, Elaine A Yu, Marjorie D Bravo, Alex Welte, Roberta L Bruhn, Mars Stone, et al. (+6)
121 [GO] 2022―Aug―03 Hyperimmune globulin for severely immunocompromised patients hospitalized with COVID-19: a randomized, controlled trial Sammy Huygens, Quincy Hofsink, Inger S Nijhof, Abraham Goorhuis, Arnon P Kater, Peter AW te Boekhorst, et al. (+7)
122 [GO] 2022―Aug―03 SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity Maria Manali, Laura A Bissett, Julien A R Amat, Nicola Logan, Sam Scott, Ellen C Hughes, et al. (+7)
123 [GO] 2022―Aug―03 Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa Natasha Samsunder, Margaretha de Vos, Sinaye Ngcapu, Jennifer Giandhari, Lara Lewis, Ayesha BM Kharsany, et al. (+7)
124 [GO] 2022―Aug―03 Potent Neutralizing Activity of Polyclonal Equine Antibodies against SARS-CoV-2 Variants of Concern Joanna Luczkowiak, Pauline Radreau, Ludovic Nguyen, Nuria Labiod, Fátima Lasala, Francisco Veas, et al. (+2)
125 [GO] 2022―Jul―30 The omicron wave modifies the COVID-19 paradigm in children with cystic fibrosis Guillaume Thouvenin, Blandine Prevost, Harriet Corvol
126 [GO] 2022―Jul―30 Correlation between post-vaccination anti-Spike antibody titres and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study Giulia Vivaldi, David A Jolliffe, Sian Faustini, Adrian M Shields, Hayley Holt, Natalia Perdek, et al. (+11)
127 [GO] 2022―Jul―30 Viral load dynamics in SARS-CoV-2 Omicron breakthrough infections Felix Dewald, Susanne Detmer, Martin Pirkl, Martin Hellmich, Eva Heger, Maximilian Herrmann, et al. (+2)
128 [GO] 2022―Jul―27 Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19 Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali, Sumathi Sivapalasingam, et al. (+27)
129 [GO] 2022―Jul―27 Memory B cell development after asymptomatic or mild symptomatic SARS-CoV-2 infection Yu Kato, Nathaniel I Bloom, Peifang Sun, Corey A Balinsky, Qi Qiu, Ying Cheng, et al. (+8)
130 [GO] 2022―Jul―26 Comment on Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults Wei Min Chu, Yung Heng Lee, James Cheng-Chung Wei, Yung Heng Lee
131 [GO] 2022―Jul―25 High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in Covid-19 Anders Tveita, Sarah Louise Murphy, Jan Cato Holter, Anders Benjamin Kildal, Annika E Michelsen, Tøri Vigeland Lerum, et al. (+22)
132 [GO] 2022―Jul―25 Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection Hans P Verkerke, Gregory L Damhorst, Daniel S Graciaa, Kaleb McLendon, William O’Sick, Chad Robichaux, et al. (+16)
133 [GO] 2022―Jul―25 Sensitivity of RT-PCR tests for SARS-CoV-2 through time Rachelle N Binny, Patricia Priest, Nigel P French, Matthew Parry, Audrey Lustig, Shaun C Hendy, et al. (+5)
134 [GO] 2022―Jul―25 Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness M Cristina Cassetti, Theodore C Pierson, L Jean Patterson, Karin Bok, Amanda J DeRocco, Anne M Deschamps, et al. (+3)
135 [GO] 2022―Jul―07 Does the co-morbidity burden contribute to suboptimal immunological responses to COVID-19 vaccination in people living with HIV? Maria Vittoria Cossu, Davide Mileto, Andrea Giacomelli, Letizia Oreni, Fiorenza Bracchitta, Martina Pellicciotta, et al. (+6)
136 [GO] 2022―Jul―05 Breakthrough infection by SARS-CoV-2 Delta and Omicron variants elicited immune response comparable to mRNA booster vaccination Suvichada Assawakosri, Nungruthai Suntronwong, Ritthideach Yorsaeng, Sitthichai Kanokudom, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan
137 [GO] 2022―Jul―01 Omicron BA.1 and BA.2 sub-lineages show reduced pathogenicity and transmission potential than the early SARS-CoV-2 D614G variant in Syrian hamsters Wen Su, Ka Tim Choy, Haogao Gu, Sin Fun Sia, Ka Man Cheng, Sarea Islam Nuha Nizami, et al. (+9)
138 [GO] 2022―Jul―01 Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults ≥1 Month After Reported SARS-CoV-2 Infection, November 1, 2021 Mark W Tenforde, Owen J Devine, Heather E Reese, Benjamin J Silk, A Danielle Iuliano, Ryan Threlkel, et al. (+11)
139 [GO] 2022―Jun―30 Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021 Tetyana I Vasylyeva, Courtney E Fang, Michelle Su, Jennifer L Havens, Edyth Parker, Jade C Wang, et al. (+7)
140 [GO] 2022―Jun―29 Placental Injury and Antibody Transfer Following COVID-19 Disease in Pregnancy Patience Timi, Sarah E Kellerhals, Naima T Joseph, Carolynn M Dude, Hans P Verkerke, Les’Shon S Irby, et al. (+4)
141 [GO] 2022―Jun―28 Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19 Josep M Llibre, Boris Revollo, Sergi Aguilar, Cristina Calomarde-Gomez, Andreu Bruguera, Raquel Martin-Iguacel
142 [GO] 2022―Jun―28 Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2 - Ondřej Vencálek, Jiří Beran, Tomáš Fürst, Zuzana Krátká, Arnošt Komárek
143 [GO] 2022―Jun―27 Anti-membrane antibodies persist at least one year and discriminate between past COVID-19 infection and vaccination Maya F Amjadi, Ryan R Adyniec, Srishti Gupta, S Janna Bashar, Aisha M Mergaert, Katarina M Braun, et al. (+6)
144 [GO] 2022―Jun―27 Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals James N Moy, Mark Anderson, Xiaoying Shen, Jia Fu, Michael Stec, Amy Gosha, et al. (+5)
145 [GO] 2022―Jun―24 Risk of severe COVID-19 disease in individuals with Down syndrome: a matched cohort study from a large, integrated health care system Jennifer H Ku, Myron J Levin, Yi Luo, Ana Florea, I-Chun Lin, Yun Tian, Hung Fu Tseng
146 [GO] 2022―Jun―24 Defective immune response to SARS-CoV-2 immunization in Down syndrome correlates with increased susceptibility to severe illness with infection T Prescott Atkinson
147 [GO] 2022―Jun―24 Decreased antibody response after SARS-CoV-2 vaccination in patients with Down Syndrome Bianca M M Streng, Marin Bont, Eveline M Delemarre, Rob S Binnendijk, Gaby Smit, Gerco den Hartog, et al. (+10)
148 [GO] 2022―Jun―20 High neutralizing antibody levels against SARS-CoV-2 Omicron BA.1 and BA.2 after UB-612 vaccine booster Farshad Guirakhoo, Shixia Wang, Chang Yi Wang, Hui Kai Kuo, Wen Jiun Peng, Hope Liu, et al. (+7)
149 [GO] 2022―Jun―17 Vaccination after SARS-CoV-2 infection increased antibody avidity against the Omicron variant compared to vaccination alone Cas LeMaster, Eric S Geanes, Elizabeth R Fraley, Rangaraj Selvarangan, Todd Bradley
150 [GO] 2022―Jun―13 Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries Mark J. Siedner, Christopher Alba, Kieran P. Fitzmaurice, Rebecca F. Gilbert, Justine A. Scott, Fatma M. Shebl, et al. (+3)
151 [GO] 2022―Jun―07 People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Gisele Umviligihozo, et al. (+36)
152 [GO] 2022―Jun―07 Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two Pandemics Jeffrey M. Jacobson
153 [GO] 2022―May―31 Functional antibody responses to SARS-CoV-2 variants in children with COVID-19, MIS-C, and after two doses of BNT162b2 vaccination Christina A. Rostad, Xuemin Chen, He-ying Sun, Laila Hussaini, Austin Lu, Maria A. Perez, et al. (+3)
154 [GO] 2022―May―31 A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients Ulrik Fahnøe, Andreas Ronit, Ronan M. G. Berg, Sofie E. Jørgensen, Trine H. Mogensen, Alexander P. Underwood, et al. (+3)
155 [GO] 2022―May―20 Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations Stephanie Zobrist, Michelle Oliveira-Silva, Alexia Martines Vieira, Pooja Bansil, Emily Gerth-Guyette, Brandon T Leader, et al. (+16)
156 [GO] 2022―May―17 Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan Masayuki Amano, Kenji Maeda, Kiyoto Tsuchiya, Shinya Shimada, Hiroaki Mitsuya
157 [GO] 2022―May―16 Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, Christopher B. Davis, Bethany M. Kwan, et al. (+8)
158 [GO] 2022―May―13 Association of SARS-CoV-2 infection and related mortality with mental disorders: an epidemiological correlation in the Indian population Sunali Padhi, Nisha Nayak, Surjyapratap Sarangi, Suraj Kumar Nahak, Abhijit Pati, Bidyutprabha Pradhan, et al. (+2)
159 [GO] 2022―May―10 Virological and serological assessment of U.S. Army trainees isolated for COVID-19 Shilpa Hakre, Ines Elakhal Naouar, David B. King, Jennifer L. Burns, Kenya N. Jackson, Stephen W. Krauss, et al. (+22)
160 [GO] 2022―May―10 Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Gisele Umviligihozo, et al. (+24)
161 [GO] 2022―May―05 Waning immunity against respiratory syncytial virus during the COVID-19 pandemic Frederic Reicherz, Rui Yang Xu, Bahaa Abu-Raya, Abdelilah Majdoubi, Christina Michalski, Liam Golding, et al. (+9)
162 [GO] 2022―May―04 Antibody duration after infection from SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey. Michael D. Swartz, Stacia M. DeSantis, Ashraf Yaseen, Frances A. Brito, Melissa A. Valerio-Shewmaker, Sarah E. Messiah, et al. (+17)
163 [GO] 2022―May―03 Low risk of SARS-CoV-2 transmission by fomites - a clinical observational study in highly infectious COVID-19 patients Toni Luise Meister, Marielen Dreismeier, Elena Vidal Blanco, Yannick Brüggemann, Natalie Heinen, Günter Kampf, et al. (+7)
164 [GO] 2022―May―03 Impact of COVID-19 Severity on Long-term Events in US Veterans using the Veterans Affairs Severity Index for COVID-19 (VASIC) Ashley Galloway, Yojin Park, Vidisha Tanukonda, Yuk-Lam Ho, Xuan-Mai T. Nguyen, Monika Maripuri, et al. (+15)
165 [GO] 2022―May―03 Cross-neutralizing activity against Omicron could be obtained in SARS-CoV-2 convalescent patients who received two doses of mRNA vaccination Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, Lidya Handayani Tjan, Sachiyo Iwata, Shigeru Sano, et al. (+10)
166 [GO] 2022―May―03 SARS-CoV-2 virus dynamics in recently infected people - data from a household transmission study Alexandra M. Mellis, Jennifer K. Meece, Natasha B. Halasa, James D. Chappell, Huong Q. McLean, Carlos G. Grijalva, et al. (+8)
167 [GO] 2022―Apr―25 Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2 Martin Šmíd, Luděk Berec, Lenka Přibylová, Ondřej Májek, Tomáš Pavlík, Jiří Jarkovský, et al. (+3)
168 [GO] 2022―Apr―21 Protection of Hamsters Challenged with SARS-CoV-2 Delta Variant after Two Doses of Adjuvanted SARS-CoV-2 Stabilized Prefusion Spike Protein (S-2P) and a Single Dose of Beta Variant S-2P Tsun-Yung Kuo, Chia En Lien, Yi-Jiun Lin, Meei-Yun Lin, Chung-Chin Wu, Wei-Hsuan Tang, et al. (+6)
169 [GO] 2022―Apr―15 SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI) Oliver Stirrup, Maria Krutikov, Gokhan Tut, Tom Palmer, David Bone, Rachel Bruton, et al. (+18)
170 [GO] 2022―Apr―15 Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron Ka-Li Zhu, Hui-Xia Gao, Lin Yao, Jun Rong, Li Yang, Zhi Zhang, et al. (+5)
171 [GO] 2022―Apr―14 Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review Chen Chen, Spencer R. Haupert, Lauren Zimmermann, Xu Shi, Lars G. Fritsche, Bhramar Mukherjee
172 [GO] 2022―Apr―14 Impact of preexisting anti-Ad26 humoral immunity on immunogenicity of the Ad26.COV2.S COVID-19 vaccine Mathieu Le Gars, Jerald Sadoff, Frank Struyf, Dirk Heerwegh, Carla Truyers, Jenny Hendriks, et al. (+5)
173 [GO] 2022―Apr―06 mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients Jennie H Kwon, Mark W Tenforde, Manjusha Gaglani, H Keipp Talbot, Adit A Ginde, Tresa McNeal, et al. (+49)
174 [GO] 2022―Mar―28 The Concept of Classical Herd Immunity May Not Apply to COVID-19 David M Morens, Gregory K Folkers, Anthony S Fauci
175 [GO] 2022―Mar―16 Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection Pyoeng Gyun Choe, Jisu Hong, Jiyoung Park, Euijin Chang, Chang Kyung Kang, Nam Joong Kim, et al. (+3)
176 [GO] 2022―Mar―14 TNFRSF1B and TNF variants are associated with differences in soluble TNF receptors' levels in patients with severe COVID-19 Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Andy Ruiz, Yadira Palacios, Gloria Pérez-Rubio, Rafael de Jesus Hernández-Zenteno, et al. (+15)
177 [GO] 2022―Mar―08 Corrigendum to: Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, et al. (+8)
178 [GO] 2022―Mar―07 IgG response to SARS-CoV-2 and seasonal coronaviruses contributes to complement overactivation in severe COVID-19 patients Priscila M S Castanha, Dylan J Tuttle, Georgios D Kitsios, Jana L Jacobs, Ulisses Braga-Neto, Matthew Duespohl, et al. (+16)
179 [GO] 2022―Mar―02 Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads Chi-Ching Kao, Yung-Po Liaw
180 [GO] 2022―Feb―28 SARS-CoV-2 nucleocapsid urine antigen in hospitalized patients with Covid-19 Nicolas Veyrenche, Amandine Pisoni, Ségolène Debiesse, Karine Bollore, Anne-Sophie Bedin, Alain Makinson, et al. (+6)
181 [GO] 2022―Feb―18 Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection Peter F Wright, Alejandra C Prevost-Reilly, Harini Natarajan, Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al. (+4)
182 [GO] 2022―Feb―16 Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages Tommy Nyberg, Katie Harman, Asad Zaidi, Shaun R Seaman, Nick Andrews, Sophie G Nash, et al. (+11)
183 [GO] 2022―Feb―15 Characterization of the immune resistance of SARS-CoV-2 Mu variant and the robust immunity induced by Mu infection Keiya Uriu, Paúl Cárdenas, Erika Muñoz, Veronica Barragan, Yusuke Kosugi, Kotaro Shirakawa, et al. (+2)
184 [GO] 2022―Feb―14 Duration of humoral immunity and cross-neutralizing activity against the Alpha, Beta, and Delta variants after wild-type SARS-CoV-2 infection: A prospective cohort study Ji Yun Noh, Jeong-Sun Yang, Soon Young Hwang, Hakjun Hyun, Hye Seong, Jin Gu Yoon, et al. (+7)
185 [GO] 2022―Feb―14 Morbidity of Respiratory Syncytial Virus-infections (RSV): RSV compared with SARS-CoV-2 infections in children aged 0 - 4 years in Cologne, Germany Meike Meyer, Esra Ruebsteck, Frank Eifinger, Florian Klein, André Oberthuer, Silke Van-Koningsbruggen-Rietschel, et al. (+2)
186 [GO] 2022―Feb―09 Detection and kinetics of subgenomic SARS-CoV-2 RNA viral load in longitudinal diagnostic RNA positive samples Meagan E Deming, Tracy Q Dong, Vaidehi Agrawal, Margaret G Mills, Meei-Li W Huang, Alexander L Greninger, et al. (+16)
187 [GO] 2022―Feb―07 Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time after SARS-CoV-2 mRNA Vaccination Iana H Haralambieva, Jonathon M Monroe, Inna G Ovsyannikova, Diane E Grill, Gregory A Poland, Richard B Kennedy
188 [GO] 2022―Jan―25 Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including variants of concern: test-negative design, British Columbia, Canada Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Hind Sbihi, et al. (+12)
189 [GO] 2022―Jan―25 Phylogenomics of SARS-CoV-2 in Emergency Shelters for People Experiencing Homelessness Amanda M Casto, Julia H Rogers, Amy C Link, Michael Boeckh, Michael L Jackson, Timothy M Uyeki, et al. (+3)
190 [GO] 2022―Jan―24 SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial Kimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, Pablo Tebas, Mary Giffear, Dinah Amante, et al. (+30)
191 [GO] 2022―Jan―12 SARS-CoV-2 Effects at the Maternal-Fetal Interface Roberta L DeBiasi
192 [GO] 2022―Jan―12 Understanding the potential drivers for respiratory syncytial virus rebound during the COVID-19 pandemic You Li, Xin Wang, Bingbing Cong, Shuyu Deng, Daniel R Feikin, Harish Nair
193 [GO] 2022―Jan―11 Intrauterine fetal demise in the third trimester of pregnancy associated with mild infection with the SARS-CoV-2 Delta variant without protection from vaccination Minhui Guan, Eric Johannesen, Cynthia Y Tang, Albert L Hsu, Courtney L Barnes, Megan Burnam, et al. (+2)
194 [GO] 2022―Jan―11 SARS-CoV-2 placentitis associated with B.1.617.2 (Delta) variant and fetal distress or demise Lydia L Shook, Sara Brigida, James Regan, James P Flynn, Abbas Mohammadi, Behzad Etemad, et al. (+5)
195 [GO] 2022―Jan―04 Effect of influenza vaccination on risk of COVID-19 - A prospective cohort study of 46,000 health care workers Jonas Henrik Kristensen, Rasmus Bo Hasselbalch, Mia Pries-Heje, Pernille Brok Nielsen, Andreas Dehlbæk Knudsen, Kamille Fogh, et al. (+23)
196 [GO] 2022―Jan―03 Lung function decline in relation to COVID-19 in the general population: a matched cohort study with pre-pandemic assessment of lung function Katrine K Iversen, Shoaib Afzal, Magnus G Ahlström, Børge G Nordestgaard, Uffe V Schneider, Lene Nielsen, et al. (+3)
197 [GO] 2022―Jan―02 Serum levels of pro-inflammatory lipid mediators and specialised pro-resolving molecules are increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response James Turnbull, Rakesh Jha, Catherine A Ortori, Eleanor Lunt, Patrick J Tighe, William L Irving, et al. (+6)
198 [GO] 2022―Jan―01 SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron Matthew T Laurie, Jamin Liu, Sara Sunshine, James Peng, Douglas Black, Anthea M Mitchell, et al. (+11)
199 [GO] 2021―Dec―27 Immunogenicity and Safety of a Three-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial Jiankai Liu, Baoying Huang, Guifan Li, Xianyun Chang, Yafei Liu, Kai Chu, et al. (+9)
200 [GO] 2021―Dec―22 Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With COVID-19 Chang Yun Hsin, Kao Chi Ching, Fang Jia Jun, Yung-Heng Lee, James Cheng-Chung Wei
201 [GO] 2021―Dec―22 Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion Veronique Nussenblatt, Allison E Roder, Sanchita Das, Emmie de Wit, Jung-Ho Youn, Stephanie Banakis, et al. (+9)
202 [GO] 2021―Dec―20 Consulting the Oracle of Chronic SARS-CoV-2 Infection Jacob E Lemieux, Jeremy Luban
203 [GO] 2021―Dec―14 Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients Coralie Geric, Mariane Saroufim, David Landsman, Jonathan Richard, Andrea Benedetti, Jane Batt, et al. (+2)
204 [GO] 2021―Dec―13 High SARS-CoV-2 viral load and low CCL5 expression levels in the upper respiratory tract are associated with COVID-19 severity Felipe Pérez-García, María Martin-Vicente, Rosa Lía Rojas-García, Lucia Castilla-García, María José Muñoz-Gomez, Irene Hervás Fernández, et al. (+6)
205 [GO] 2021―Dec―09 Sequential delivery of LAIV and SARS-CoV-2 in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology Kathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, Susan A Fotheringham, Yper Hall, Richard Humphreys, et al. (+8)
206 [GO] 2021―Dec―08 Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, Cristhian Berrios Mairena, Julia C Thierauf, Grace Kirkpatrick, et al. (+19)
207 [GO] 2021―Dec―07 Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults Mark A Brockman, Francis Mwimanzi, Hope R Lapointe, Yurou Sang, Olga Agafitei, Peter Cheung, et al. (+20)
208 [GO] 2021―Dec―01 Maternal-fetal immunologic response to SARS-CoV-2 infection in a symptomatic vulnerable population: A prospective cohort Ramon Larcade, Lise DeShea, Gillian A Lang, Mauricio T Caballero, Adrian Ferretti, William H Beasley, et al. (+6)
209 [GO] 2021―Nov―29 Gene Expression Risk Scores for COVID-19 Illness Severity Derick R Peterson, Andrea M Baran, Soumyaroop Bhattacharya, Angela R Branche, Daniel P Croft, Anthony M Corbett, et al. (+3)
210 [GO] 2021―Nov―16 COVID-19 Vaccination Rates in a Global HIV Cohort Evelynne S Fulda, Kathleen V Fitch, Edgar T Overton, Markella V Zanni, Judith A Aberg, Judith S Currier, et al. (+8)
211 [GO] 2021―Nov―15 COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals Ai-Ris Y Collier, Jingyou Yu, Katherine Mcmahan, Jinyan Liu, Caroline Atyeo, Jessica L Ansel, et al. (+15)
212 [GO] 2021―Nov―10 Corrigendum to: Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Communities and the Coronavirus Disease 2019 Pandemic: A Call to Break the Cycle of Structural Barriers Raul Macias Gil, Tracey L Freeman, Trini Mathew, Ravina Kullar, Thomas Fekete, Anais Ovalle, et al. (+5)
213 [GO] 2021―Nov―06 Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma Dung Nguyen, Julie Xiao, Peter Simmonds, Abigail Lamikanra, Valerie Odon, Jeremy Ratcliff, et al. (+3)
214 [GO] 2021―Nov―05 SARS-CoV-2 monoclonal antibody combination therapy in patients with COVID-19 and primary antibody deficiency Federica Pulvirenti, Cinzia Milito, Francesco Cinetto, Ane Fernandez Salinas, Sara Terreri, Eva Piano Mortari, et al. (+8)
215 [GO] 2021―Oct―28 Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient Jonathan Klein, Anderson F Brito, Paul Trubin, Peiwen Lu, Patrick Wong, Tara Alpert, et al. (+25)
216 [GO] 2021―Oct―20 Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, Katherine Pohida, Marana S Tso, Emily C Samuels, et al. (+25)
217 [GO] 2021―Oct―12 Frequent Sars-Cov-2 Antigen Testing In A Disease-Free Population C S Lau, T C Aw
218 [GO] 2021―Oct―11 Angiotensin-converting enzyme 2 (ACE-2) genetic variants are associated with coronavirus disease 19 Abhijit Pati, Sunali Padhi, Tapan Kumar Singh Nayak, Aditya K Panda
219 [GO] 2021―Oct―04 Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the pre-vaccine period Yun Lu, Yixin Jiao, David J Graham, Yue Wu, Jing Wang, Mikhail Menis, et al. (+5)
220 [GO] 2021―Sep―20 Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States Yuchen Qi, Jeffrey Shaman, Sen Pei
221 [GO] 2021―Sep―20 The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks Rodric V Francis, Harriet Billam, Mitch Clarke, Carl Yates, Theocharis Tsoleridis, Louise Berry, et al. (+7)
222 [GO] 2021―Sep―17 Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Michael Karbiener, Maria R Farcet, Julia Schwaiger, Nicholas Powers, James Lenart, Joseph M Stewart, et al. (+2)
223 [GO] 2021―Sep―11 The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 Surveillance How concurrent epidemics may introduce bias and decrease the observed SARS-CoV-2 percent positivity Aleksandra Kovacevic, Rosalind M Eggo, Marc Baguelin, Matthieu Domenech de Cellès, Lulla Opatowski
224 [GO] 2021―Sep―10 Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents Jens T Van Praet, Stefaan Vandecasteele, Anneleen De Roo, Matthijs Vynck, An S De Vriese, Marijke Reynders
225 [GO] 2021―Sep―08 mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021 Sara S Kim, Jessie R Chung, Edward A Belongia, Huong Q McLean, Jennifer P King, Mary Patricia Nowalk, et al. (+16)
226 [GO] 2021―Sep―08 Baseline SARS-CoV-2 Viral Load is Associated With COVID-19 Disease Severity and Clinical Outcomes: Post-Hoc Analyses of a Phase 2/3 Trial Anita Boyapati, Matthew F Wipperman, Peter J Ehmann, Sara Hamon, David J Lederer, Alpana Waldron, et al. (+7)
227 [GO] 2021―Sep―07 Characteristics of Persons with Secondary Detection of SARS-CoV-2 ≥90 days After First Detection - New Mexico, 2020 Joseph T Hicks, Smita Das, Almea Matanock, Anastacia Griego-Fisher, Daniel Sosin
228 [GO] 2021―Sep―04 Persistence of the immune responses and cross-neutralizing activity with Variants of Concern following two doses of adjuvanted SCB-2019 COVID-19 vaccine Peter C Richmond, Lara Hatchuel, Filippo Pacciarini, Branda Hu, Igor Smolenov, Ping Li, et al. (+4)
229 [GO] 2021―Aug―24 Potential effect of previous HCoV-NL63 infection on the rate of infection and the clinical course of COVID-19 M Hukić, H Avdihodžić, E Veledar, E Korkut
230 [GO] 2021―Aug―24 Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection Angélica Arcanjo, Kamila Guimarães Pinto, Jorgete Logullo, Paulo Emílio Corrêa Leite, Camilla Cristie Barreto Menezes, Leonardo Freire-de-Lima, et al. (+13)
231 [GO] 2021―Aug―24 SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion Felix Buder, Markus Bauswein, Clara L Magnus, Franz A�rt, Henriette Lang, Christof Kundel, et al. (+15)
232 [GO] 2021―Aug―21 Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19) Yiu Chung Lau, Tim K Tsang, Lee Kennedy-Shaffer, Rebecca Kahn, Eric H Y Lau, Dongxuan Chen, et al. (+4)
233 [GO] 2021―Aug―18 Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies? Rosa de Miguel Buckley, Marta Díaz-Menéndez, Julio García-Rodríguez, José Ramón Arribas
234 [GO] 2021―Aug―18 SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents Nadia Nathan, Blandine Prevost, Sidonie Lambert, Aurélie Schnuriger, Harriet Corvol
235 [GO] 2021―Aug―17 Interpreting prevention of COVID-19 and vaccines Chi Ya Yang, Yi Yang Lee, James Cheng-Chung Wei
236 [GO] 2021―Aug―12 Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study Daniel B Horton, Emily S Barrett, Jason Roy, Maria Laura Gennaro, Tracy Andrews, Patricia Greenberg, et al. (+20)
237 [GO] 2021―Aug―11 SARS-CoV-2 Specific Monoclonal Antibody for the Treatment of Mild-to-Moderate COVID-19 in Cancer Patients: A Single-center Experience Alfredo G Puing, Stephanie Ho, Paul Frankel, Bernard Tegtmeier, Abigail Martin, Justine Ross, et al. (+6)
238 [GO] 2021―Aug―09 Distinct mitochondria-mediated T cells apoptosis responses in children and adults with COVID-19 Yang Yang, Kuang Liangjian, Linhai Li, Wu Yongjian, Bei Zhong, Xi Huang
239 [GO] 2021―Jul―30 Editorial: COVID-19 severity in obese patients may be linked to viral load and immune response Alexander M Lewis, Xinya Zhang, Jonathan R  Brestoff
240 [GO] 2021―Jul―30 Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries Nusrat J Epsi, Stephanie A Richard, Eric D Laing, Anthony C Fries, Eugene Millar, Mark P Simons, et al. (+17)
241 [GO] 2021―Jul―29 SARS-CoV-2 normalized viral loads and subgenomic RNA detection as tools for improving clinical decision-making and work reincorporation Marta Santos Bravo, David Nicolás, Carla Berengua, Mariana Fernandez, Juan Carlos Hurtado, Marta Tortajada, et al. (+5)
242 [GO] 2021―Jul―28 The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers Raul Macias Gil, Tracey Freeman, Trini Mathew, Ravina Kullar, Anais Ovalle, Don Nguyen, et al. (+4)
243 [GO] 2021―Jul―22 Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates Kristen K Bjorkman, Tassa K Saldi, Erika Lasda, Leisha Conners Bauer, Jennifer Kovarik, Patrick K Gonzales, et al. (+10)
244 [GO] 2021―Jul―21 Inter-subject variation in ACE2 protein expression in human airway epithelia and its relationship to SARS-CoV-2 infection Kun Li, Christine Wohlford-Lenane, Jennifer A Bartlett, Paul B McCray
245 [GO] 2021―Jul―19 Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection Stéphane Pelleau, Tom Woudenberg, Jason Rosado, Françoise Donnadieu, Laura Garcia, Thomas Obadia, et al. (+37)
246 [GO] 2021―Jul―17 Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019 Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, Ryan J Anderson, Lori L Arndt, Richard F Arndt, et al. (+13)
247 [GO] 2021―Jul―16 Not All Monoclonal Antibodies for COVID-19 Are Created Equal Valentina Stosor, Michael P Angarone
248 [GO] 2021―Jul―13 SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion Isabella Ferreira, Steven Kemp, Rawlings Datir, Akatsuki Saito, Bo Meng, Partha Rakshit, et al. (+11)
249 [GO] 2021―Jul―12 Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
250 [GO] 2021―Jul―12 Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities Niall J Lennon, Roby P Bhattacharyya, Michael J Mina, Heidi L Rehm, Deborah T Hung, Sandra Smole, et al. (+3)
251 [GO] 2021―Jul―08 Molnupiravir inhibits the replication of the emerging SARS-CoV-2 variants of concern (VoCs) in a hamster infection model Rana Abdelnabi, Caroline S Foo, Steven De Jonghe, Piet Maes, Birgit Weynand, Johan Neyts
252 [GO] 2021―Jul―02 Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing Talya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, Marcos C Schechter, Paulina A Rebolledo, Vyjayanti Kasinathan, et al. (+19)
253 [GO] 2021―Jul―02 Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro Marek Widera, Alexander Wilhelm, Sebastian Hoehl, Christiane Pallas, Niko Kohmer, Timo Wolf, et al. (+7)
254 [GO] 2021―Jun―30 Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland Andrew Beverland, Mary Keogan, Jeff Connell, Cillian De Gascun, Derval Igoe
255 [GO] 2021―Jun―29 Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Ming Tong, Qing Zheng, Fang Chen, Yimin Zhu
256 [GO] 2021―Jun―29 Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Markus K Kristensen, Ronni R Plovsing, Ronan M G Berg, Rikke Krogh Madsen, Andreas Ronit
257 [GO] 2021―Jun―24 Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection Pyoeng Gyun Choe, Chang Kyung Kang, Kye-Hyung Kim, Jongyoun Yi, Eu Suk Kim, San Won Park, et al. (+3)
258 [GO] 2021―Jun―22 Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples Khalid Sharwani, Ravi Sharma, Madhan Krishnan, Terry Jones, Martin Mayora-Neto, Diego Cantoni, et al. (+7)
259 [GO] 2021―Jun―21 Accelerating the evolution of SARS-CoV-2 - a risk of combining dexamethasone and tocilizumab for severe COVID-19 David Koeckerling, Joseph Barker
260 [GO] 2021―Jun―19 Early Convalescent Plasma Therapy and Mortality among US Veterans Hospitalized with Non-Severe COVID-19: An Observational Analysis Emulating a Target Trial Kelly Cho, Sarah C Keithly, Katherine E Kurgansky, Arin L Madenci, Hanna Gerlovin, Helen M Wellman, et al. (+18)
261 [GO] 2021―Jun―16 Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19 Yipeng Ma, Fenglan Liu, Tong Lin, Lei Chen, Aixin Jiang, Geng Tian, et al. (+2)
262 [GO] 2021―Jun―15 Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City Sarah L Braunstein, Jennifer Sanderson Slutsker, Rachael Lazar, Dipal Shah, Robin R Hennessy, Shirley Chen, et al. (+3)
263 [GO] 2021―Jun―09 COVID-19 mRNA vaccination generates greater IgG levels in women compared to men Alexis R Demonbreun, Amelia Sancilio, Matt E Velez, Daniel T Ryan, Lorenzo Pesce, Rana Saber, et al. (+7)
264 [GO] 2021―Jun―07 Proper assignation of reactivation in a COVID-19 recurrence initially interpreted as a reinfection Laura Pérez Lago, Helena Martínez Lozano, Jose Antonio Pajares Díaz, Arantxa Díaz Gómez, Marina Machado, Pedro J Sola-Campoy, et al. (+11)
265 [GO] 2021―Jun―04 Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age Daniel Pichler, Matthias Baumgartner, Janine Kimpel, Annika Rössler, Lydia Riepler, Katie Bates, et al. (+4)
266 [GO] 2021―Jun―04 Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection Valeria De Giorgi, Kamille A West, Amanda N Henning, Leonard N Chen, Michael R Holbrook, Robin Gross, et al. (+7)
267 [GO] 2021―Jun―04 A multiregional evaluation of Ct values in SARS-CoV-2 VOC-20DEC-01 variant K J Hill, R Dewar, K Templeton
268 [GO] 2021―Jun―03 Accounting for imported cases in estimating the time-varying reproductive number of COVID-19 in Hong Kong Tim K Tsang, Peng Wu, Eric H Y Lau, Benjamin J Cowling
269 [GO] 2021―Jun―03 Clarification regarding Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Nooshin Razani, Mohsen Malekinejad, George W Rutherford
270 [GO] 2021―Jun―03 Prevalence of SARS-CoV-2 antibodies in New York City adults, June-October, 2020: a population-based survey Jannae C Parrott, Ariana N Maleki, Valerie E Vassor, Sukhminder Osahan, Yusyin Hsin, Michael Sanderson, et al. (+9)
271 [GO] 2021―May―31 Corrigendum to: Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
272 [GO] 2021―May―25 SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model Bart L Haagmans, Danny Noack, Nisreen M A Okba, Wentao Li, Chunyan Wang, Theo Bestebroer, et al. (+16)
273 [GO] 2021―May―06 Prolonged COVID-19 Disease in a Patient with Rheumatoid Arthritis on Rituximab Therapy Rachel Aviv, Andrew Weber, Tarif Anzum, Matthew Federbush, Diane Horowitz, Effie Singas
274 [GO] 2021―May―05 β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells Shuntai Zhou, Collin S Hill, Sanjay Sarkar, Longping V Tse, Blaide M D Woodburn, Raymond F Schinazi, et al. (+4)
275 [GO] 2021―Apr―23 Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19 Enrique Bernal, Lourdes Gimeno, María J Alcaraz, Ahmed A Q귮r, Marta Moreno, María V Martínez-Sánchez, et al. (+13)
276 [GO] 2021―Apr―20 Corrigendum to: Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure due to Ethical and Practical Issues Stanley M Spinola, Gregory D Zimet, Mary A Ott, Barry P Katz
277 [GO] 2021―Apr―06 A Silver Lining? Fewer non-SARS-CoV-2 Respiratory Viruses during the COVID-19 Pandemic Zachary M Most, Michael Holcomb, Andrew R Jamieson, Trish M Perl
278 [GO] 2021―Mar―23 Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA) Frederic Lamoth, Russell E Lewis, Thomas J Walsh, Dimitrios P Kontoyiannis
279 [GO] 2021―Mar―20 Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, et al. (+8)
280 [GO] 2021―Mar―19 Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms Janet L Cunningham, Johan Virhammar, Bengt Rönnberg, Xaquin Castro Dopico, Linda Kolstad, Bo Albinsson, et al. (+9)
281 [GO] 2021―Mar―15 Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic Maria R Farcet, Michael Karbiener, Julia Schwaiger, Reinhard Ilk, Thomas R Kreil
282 [GO] 2021―Mar―13 Role of asymptomatic children in community SARS-CoV-2 transmission Liangjian Lu, Chee Teck Koh, Yi Herng Lim, Andrew Sng, Kok Siong Poon, Shaun S Y Tan, et al. (+5)
283 [GO] 2021―Mar―11 Comment on: Nature and Dimensions of the Systemic Hyper-Inflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Yeny Acosta-Ampudia, Manuel Rojas, Diana M Monsalve, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya
284 [GO] 2021―Mar―11 Complement Induced Endotheliopathy Associated Vascular Microthrombosis in Coronavirus 2019 Disease H Bradford Hawley, Jae C Chang
285 [GO] 2021―Mar―09 The Association of COVID-19 Risk Perception, County Death Rates, and Voluntary Health Behaviors among U.S. Adult Population Jad A Elharake, Mehr Shafiq, SarahAnn M McFadden, Amyn A Malik, Saad B Omer
286 [GO] 2021―Feb―18 Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats Linlin Bao, Zhiqi Song, Jing Xue, Hong Gao, Jiangning Liu, Jie Wang, et al. (+21)
287 [GO] 2021―Feb―16 The Cat’s in the Bag: Despite limited cat-to-cat SARS-CoV-2 transmission, One Health surveillance efforts are needed Meghan F Davis, Gabriel K Innes
288 [GO] 2021―Feb―12 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader Vasanthi Avadhanula, Erin G Nicholson, Laura Ferlic-Stark, Felipe-Andres Piedra, Brittani N Blunck, Sonia Fragoso, et al. (+9)
289 [GO] 2021―Feb―12 A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy Raman R S, Vijaykumar Bhagwan Barge, Anil Kumar Darivenula, Himanshu Dandu, Rakesh R Kartha, Varun Bafna, et al. (+2)
290 [GO] 2021―Feb―11 High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers Joakim Dillner, K Miriam Elfström, Jonas Blomqvist, Lars Engstrand, Mathias Uhlén, Carina Eklund, et al. (+21)
291 [GO] 2021―Feb―03 UVB radiation alone may not explain sunlight inactivation of SARS-CoV-2 Paolo Luzzatto-Fegiz, Fernando Temprano-Coleto, François J Pea�rf, Julien R Landel, Yangying Zhu, Julie A McMurry
292 [GO] 2021―Jan―27 Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) Sumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, Aya Nakamura, Thomas Conrad, Mohamed Hassanein, et al. (+12)
293 [GO] 2021―Jan―25 Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department Wolfgang Bauer, Jannis Ulke, Noa Galtung, Leonore Claudia Strasser-Marsik, Nick Neuwinger, Rudolf Tauber, et al. (+2)
294 [GO] 2021―Jan―23 Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis Asma Boumaza, Laetitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moise Michel, et al. (+7)
295 [GO] 2021―Jan―19 Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial Joshua M Thiede, Abigail R Gress, Samuel D Libby, Christine E Ronayne, William E Matchett, Brooke Noren, et al. (+5)
296 [GO] 2021―Jan―02 Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants Christine H T Bui, H W Yeung, John C W Ho, Connie Y H Leung, Kenrie P Y Hui, Ranawaka A P M Perera, et al. (+5)
297 [GO] 2020―Dec―23 SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
298 [GO] 2020―Dec―21 Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic Jeffrey R Strich, Marcos J Ramos-Benitez, Davide Randazzo, Sydney R Stein, Ashley Babyak, Richard T Davey, et al. (+3)
299 [GO] 2020―Dec―14 Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries Hector S Izurieta, David J Graham, Yixin Jiao, Mao Hu, Yun Lu, Yue Wu, et al. (+6)
300 [GO] 2020―Dec―03 Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients E Petito, E Falcinelli, U Paliani, E Cesari, G Vaudo, M Sebastiano, et al. (+10)
301 [GO] 2020―Dec―02 SARS-CoV-2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells Jian Zheng, Yuhang Wang, Kun Li, David K Meyerholz, Chantal Allamargot, Stanley Perlman
302 [GO] 2020―Nov―27 Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Tommaso Celeste Bulfone, Mohsen Malekinejad, George W Rutherford, Nooshin Razani
303 [GO] 2020―Nov―17 Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19 Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, Frank Mennechet, Fabrice Malergue, Amandine Pisoni, et al. (+14)
304 [GO] 2020―Nov―12 Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses Karoline Leuzinger, Tim Roloff, Rainer Gosert, Kirstin Sogaard, Klaudia Naegele, Katharina Rentsch, et al. (+12)
305 [GO] 2020―Nov―11 Long-term survival of SARS-CoV-2 on salmon as a source for international transmission Manman Dai, Huanan Li, Nan Yan, Jinyu Huang, Li Zhao, Siqi Xu, et al. (+4)
306 [GO] 2020―Nov―09 Corrigendum to: Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study Xinghua Liu, Jianqiao Tang, Rong Xie, Wei Li, Jianying Chen, Yan Guo, et al. (+8)
307 [GO] 2020―Nov―05 Possible auto-antigens that may explain the post-infection autoimmune manifestations in COVID-19 patients displaying neurological conditions Mugdha Mohkhedkar, Siva Sai Krishna Venigalla, Vani Janakiraman
308 [GO] 2020―Oct―28 On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community E Goldstein, M Lipsitch, M Cevik
309 [GO] 2020―Oct―14 Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing Bernd Jahrsdörfer, Joris Kroschel, Carolin Ludwig, Victor Max Corman, Tatjana Schwarz, Sixten Körper, et al. (+8)
310 [GO] 2020―Oct―06 Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR Eelke Brandsma, Han J M P Verhagen, Thijs J W van de Laar, Eric C J Claas, Marion Cornelissen, Emile van den Akker
311 [GO] 2020―Oct―06 Low incidence of reinfection with endemic coronaviruses diagnosed by RT-PCR Johan Ringlander, Staffan Nilsson, Johan Westin, Magnus Lindh, Anna Martner, Kristoffer Hellstrand
312 [GO] 2020―Oct―03 Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19 Aylin Yilmaz, Emelie Marklund, Maria Andersson, Staffan Nilsson, Lars-Magnus Andersson, Magnus Lindh, Magnus Gisslén
313 [GO] 2020―Oct―03 Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 Toni Luise Meister, Yannick Brüggemann, Daniel Todt, Carina Conzelmann, Janis A Müller, Rüdiger Groß, et al. (+6)
314 [GO] 2020―Oct―01 From Foe to Friend in COVID-19: RAS Inhibitors Jason Kidde, Amirhossein Sahebkar
315 [GO] 2020―Oct―01 Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records Dadong Li, Donna M Wolk, Michael N Cantor
316 [GO] 2020―Oct―01 Minor allele of Interferon-Induced Transmembrane Protein-3 (IFITM3) polymorphism (rs12252) is covered against SARS-CoV-2 infection and mortality: a worldwide epidemiological investigation Abhijit Pati, Sunali Padhi, Subham Suvankar, Aditya K Panda
317 [GO] 2020―Sep―26 Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Massimo Crabbio, Eugenio Magni, Valeria De Giuli, et al. (+23)
318 [GO] 2020―Sep―16 No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic Julia Schwaiger, Michael Karbiener, Claudia Aberham, Maria R Farcet, Thomas R Kreil
319 [GO] 2020―Sep―15 A granulocytic signature identifies COVID-19 and its severity Joana Vitte, Aïssatou Bailo Diallo, Asma Boumaza, Alexandre Lopez, Moïse Michel, Jérôme Allardet-Servent, et al. (+10)
320 [GO] 2020―Sep―09 Corrigendum to: COVID-19 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
321 [GO] 2020―Sep―09 Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
322 [GO] 2020―Sep―08 Post-Mortem Findings in Italian Patients with COVID-19 - a Descriptive Full Autopsy Study of cases with and without co-morbidities Laura Falasca, Roberta Nardacci, Daniele Colombo, Eleonora Lalle, Antonino Di Caro, Emanuele Nicastri, et al. (+11)
323 [GO] 2020―Sep―08 SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors Sarah E Benner, Eshan U Patel, Oliver Laeyendecker, Andrew Pekosz, Kirsten Littlefield, Yolanda Eby, et al. (+19)
324 [GO] 2020―Sep―02 A study of universal SARS-CoV-2 RNA testing of residents and staff in a large group of care homes in South London Agnes Marossy, Stefan Rakowicz, Angela Bhan, Sarah Noon, Amanda Rees, Manjinder Virk, et al. (+5)
325 [GO] 2020―Sep―01 Immunosenescence and SARS-CoV-2 Vaccine Development David Nalin
326 [GO] 2020―Aug―04 Clinical and epidemiological features of 46 children under 1 year old with coronavirus disease 2019 (COVID-19) in Wuhan, China: a descriptive study Xinghua Liu, Rong Xie, Wei Li, Yan Guo, Bo Zhang, Yue Zhang, et al. (+8)
327 [GO] 2020―Aug―04 Factors associated with viral load kinetics of Middle East respiratory syndrome coronavirus during the 2015 outbreak in South Korea Jeong-Sun Yang, Min-Gyu Yoo, Hye-Ja Lee, Han Byul Jang, Hee-Dong Jung, Jeong-Gu Nam, et al. (+3)
328 [GO] 2020―Aug―04 Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Q, Canada Rodica Gilca, Sara Carazo, Rachid Amini, Hugues Charest, Gaston De Serres
329 [GO] 2020―Aug―04 SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence Gerco den Hartog, Rutger M Schepp, Marjan Kuijer, Corine GeurtsvanKessel, Josine van Beek, Nynke Rots, et al. (+3)
330 [GO] 2020―Aug―04 Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting Katherine Bond, Suellen Nicholson, Seok Ming Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnson, et al. (+9)
331 [GO] 2020―Aug―01 Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques Bon-Sang Koo, Hanseul Oh, Green Kim, Eun-Ha Hwang, Hoyin Jung, Youngjeon Lee, et al. (+4)
332 [GO] 2020―Jul―31 Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19) Christopher K C Lai, Zigui Chen, Grace Lui, Lowell Ling, Timothy Li, Martin C S Wong, et al. (+9)
333 [GO] 2020―Jul―31 COVID-19 epidemic doubling time in the United States before and during stay-at-home restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
334 [GO] 2020―Jul―31 Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients María Teresa Schiaffino, Marisa Di Natale, Elena García-Martínez, Joaquín Navarro, José Luis Muñoz-Blanco, Pablo Demelo-Rodríguez, Paloma Sánchez-Mateos
335 [GO] 2020―Jul―17 Environmental sampling for severe acute respiratory syndrome coronavirus 2 during COVID-19 outbreak in the Diamond Princess cruise ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
336 [GO] 2020―Jul―06 Direct observation of repeated infections with endemic coronaviruses Marta Galanti, Jeffrey Shaman
337 [GO] 2020―Jul―05 Overcoming Challenges in COVID-19 Translational Research Jonathan Z Li, Xu G Yu
338 [GO] 2020―Jun―28 The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics Wenjun Wang, Xiaoqing Liu, Sipei Wu, Sibei Chen, Yimin Li, Lingbo Nong, et al. (+5)
339 [GO] 2020―Jun―26 Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study Ding Shi, Wenrui Wu, Qing Wang, Kaijin Xu, Jiaojiao Xie, Jingjing Wu, et al. (+7)
340 [GO] 2020―Jun―24 Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV Hsi-en Ho, Michael J Peluso, Colton Margus, Joao Pedro Matias Lopes, Chen He, Michael M Gaisa, et al. (+3)
341 [GO] 2020―Jun―23 Racial Disparity of Coronavirus Disease 2019 (COVID-19) in African American Communities Ravina Kullar, Jasmine R Marcelin, Talia H Swartz, Damani A Piggott, Raul Macias Gil, Trini A Mathew, Tina Tan
342 [GO] 2020―Jun―23 Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence Christopher D Pilcher, Daniel Westreich, Michael G Hudgens
343 [GO] 2020―Jun―20 Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
344 [GO] 2020―Jun―19 Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China Ying Chi, Yiyue Ge, Bin Wu, Wenshuai Zhang, Tao Wu, Tian Wen, et al. (+7)
345 [GO] 2020―Jun―16 Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19 Luis Ibáñez-Samaniego, Federico Bighelli, Clara Usón, Celia Caravaca, Carlos Fernández Carrillo, Miriam Romero, et al. (+9)
346 [GO] 2020―Jun―16 Ethical implementation of ‘immunity passports’ during the COVID-19 pandemic Teck Chuan Voo, Hannah Clapham, Clarence C Tam
347 [GO] 2020―Jun―16 Identifying capability framework that could mitigate the COVID-19 pandemic in global health community Martin C S Wong, Junjie Huang, Jeremy Y C Teoh, Sunny H Wong
348 [GO] 2020―Jun―16 Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation Dong Yang, Hin Chu, Yuxin Hou, Yue Chai, Huiping Shuai, Andrew Chak-Yiu Lee, et al. (+11)
349 [GO] 2020―Jun―15 Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection Nicola Clementi, Roberto Ferrarese, Elena Criscuolo, Roberta Antonia Diotti, Matteo Castelli, Carolina Scagnolari, et al. (+4)
350 [GO] 2020―Jun―08 Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight Michael Schuit, Shanna Ratnesar-Shumate, Jason Yolitz, Gregory Williams, Wade Weaver, Brian Green, et al. (+13)
351 [GO] 2020―Jun―05 Corrigendum to: A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage Yuxia Cui, Maolu Tian, Dong Huang, Xike Wang, Yuying Huang, Li Fan, et al. (+13)
352 [GO] 2020―Jun―03 Estimating global epidemiology of low pathogenic human coronaviruses relating to the COVID-19 context Pengfei Li, Jiaye Liu, Zhongren Ma, Wichor M Bramer, Maikel P Pepelenbosch, Qiuwei Pan
353 [GO] 2020―Jun―03 SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon Liza Dawson, Jake Earl, Jeffrey Livezey
354 [GO] 2020―May―29 TPE-nAbs combination therapy for severe COVID-19 Miroslav Malkovsky
355 [GO] 2020―May―29 Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study Shaorui Hao, Jiangshan Lian, Yingfeng Lu, Hongyu Jia, Jianhua Hu, Guodong Yu, et al. (+17)
356 [GO] 2020―May―29 Multistate Outbreak of Seoul virus: Implications for the One Health Movement and Pandemic Preparedness Mary-Margaret A Fill
357 [GO] 2020―May―27 Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests M Traugott, S W Aberle, J H Aberle, H Griebler, M Karolyi, E Pawelka, et al. (+3)
358 [GO] 2020―May―21 Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice Linlin Bao, Hong Gao, Wei Deng, Qi Lv, Haisheng Yu, Mingya Liu, et al. (+19)
359 [GO] 2020―May―20 Testing for Novel Covid-19 antibodies: a necessary adjunct Marco Daverio, Angela Amigoni, Maria Elena Cavicchiolo
360 [GO] 2020―May―19 Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus Shuaiyin Chen, Xin Zheng, Jingyuan Zhu, Ronghua Ding, Yuefei Jin, Weiguo Zhang, et al. (+4)
361 [GO] 2020―May―16 Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients Peter D Burbelo, Francis X Riedo, Chihiro Morishima, Stephen Rawlings, Davey Smith, Sanchita Das, et al. (+4)
362 [GO] 2020―May―16 Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs Lin Li, Xiao Li, Zhengdong Guo, Zhongyi Wang, Ke Zhang, Chao Li, et al. (+2)
363 [GO] 2020―May―06 T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19 Mei Jiang, Yang Guo, Qing Luo, ZiKun Huang, Rui Zhao, ShuYuan Liu, et al. (+3)
364 [GO] 2020―May―04 A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19) Xue-fei Cai, Juan Chen, Jie-li Hu, Quan-xin Long, Hai-jun Deng, Kai Fan, et al. (+28)
365 [GO] 2020―May―04 Clinical characteristics of patients with COVID-19 in Japan: a single-center case series Ken-ichiro Kobayashi, Takahiro Kaki, Shinsuke Mizuno, Kenji Kubo, Nobuhiro Komiya, Satoko Otsu
366 [GO] 2020―Apr―30 Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development Kevin W Graepel, Sonali Kochhar, Ellen W Clayton, Kathryn E Edwards
367 [GO] 2020―Apr―28 Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, et al. (+10)
368 [GO] 2020―Apr―28 Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 Guoxin Zhang, Shuke Nie, Zhaohui Zhang, Zhentao Zhang
369 [GO] 2020―Apr―28 Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients Qing-Lei Zeng, Zu-Jiang Yu, Jian-Jun Gou, Guang-Ming Li, Shu-Huan Ma, Guo-Fan Zhang, et al. (+8)
370 [GO] 2020―Apr―23 COVID-19: Is Everything Appropriate to Create an Effective Vaccine? Andrea Cioffi
371 [GO] 2020―Apr―22 Epidemiological characteristics and incubation period of 7,015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China Xiuquan Nie, Lieyang Fan, Ge Mu, Qiyou Tan, Mengyi Wang, Yujia Xie, et al. (+4)
372 [GO] 2020―Apr―21 Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China Xiao-Lin Jiang, Xiao-Li Zhang, Xiang-Na Zhao, Cun-Bao Li, Jie Lei, Zeng-Qiang Kou, et al. (+13)
373 [GO] 2020―Apr―21 Desperate times call for temperate measures: practicing infectious diseases during a novel pandemic Mark J Siedner, Rajesh T Gandhi, Arthur Y Kim
374 [GO] 2020―Apr―20 Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers Yanfeng Pan, Xue Yu, Xinwei Du, Qingqing Li, Xianyang Li, Tao Qin, et al. (+7)
375 [GO] 2020―Apr―15 Airborne or droplet precautions for health workers treating COVID-19? Prateek Bahl, Con Doolan, Charitha de Silva, Abrar Ahmad Chughtai, Lydia Bourouiba, C Raina MacIntyre
376 [GO] 2020―Apr―14 Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence Sema Nickbakhsh, Antonia Ho, Diogo F P Marques, Jim McMenamin, Rory N Gunson, Pablo R Murcia
377 [GO] 2020―Apr―08 My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists Jawara Allen
378 [GO] 2020―Apr―03 Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan Arnold S Monto, Peter DeJonge, Amy P Callear, Latifa A Bazzi, Skylar Capriola, Ryan E Malosh, et al. (+2)
379 [GO] 2020―Mar―31 Human challenge studies to accelerate coronavirus vaccine licensure Nir Eyal, Marc Lipsitch, Peter G Smith
380 [GO] 2020―Mar―28 Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia Fan Wang, Jiayan Nie, Haizhou Wang, Qiu Zhao, Yong Xiong, Liping Deng, et al. (+4)
381 [GO] 2020―Mar―14 Public health measures to slow community spread of COVID-19 Benjamin J Cowling, Allison Aiello
382 [GO] 2020―Feb―15 A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period Ping Yu, Jiang Zhu, Zhengdong Zhang, Yingjun Han
 [1] 

382 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.023 sec